WHO Officials Fear Latest Ebola Outbreak in Congo Could Spread to Big Cities

Two cases in the western part of the country have been confirmed

A health worker walks at an Ebola quarantine unit on June 13, 2017 in Muma, Congo.

The new Ebola outbreak on the western edge of the Democratic Republic of the Congo has ignited serious concern at the World Health Organization, with signs pointing to an epidemic that may have been underway for weeks or months.

Though there are only two confirmed cases at this point, preliminary investigations point to cases in several locations that may date back as far as early this year, Dr. Pierre Formenty, the WHO’s top Ebola expert told STAT. There is also fear that two health care workers may be among the infected, which happens often in Ebola outbreaks and can fuel the disease’s spread.

The country’s ministry of health, which declared the outbreak on Tuesday, said then that there are at least 21 people known to have symptoms consistent with Ebola, and 17 of whom have died.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


While the outbreak is in a remote area where road travel is taxing and slow, one of the towns where cases may be occurring, Bikoro, is a port on a lake that connects to the Congo River. That opens up the disturbing specter of infected individuals traveling by boat to DRC’s densely populated capital, Kinshasa, or to Brazzaville, the capital of the neighboring Republic of the Congo.

“If it was only the roads, we know that the roads are very bad and that it’s difficult for people to travel. But if you reach Bikoro and you take a boat … everything could happen,” Formenty said in an interview on Wednesday.

“For us it’s a worrying situation in a bad context in terms of logistics. And we need to go fast.”

The population of Kinshasa is roughly 11.6 million while about 2 million people live in Brazzaville.

Formenty spoke to STAT after a more than two-hour-long conference call with organizations that will be involved in planning and executing the outbreak response.

He said a team made up of people from DCR’s ministry of health, the WHO, Doctors Without Borders—which takes the lead on running Ebola treatment units during outbreaks—arrived in Bikoro on Wednesday. Formenty will travel there this weekend.

Over the next few days, more responders will be sent to the area to set up testing and treatment operations, plan for an expected vaccination campaign, and investigate how big the outbreak is and how far it may have spread.

Formenty said the WHO is in talks with the governments of the Democratic Republic of the Congo and the Republic of the Congo to try to set up a system to control movement of boats on the Congo River, hoping to intercept and assess anyone who may be sick.

Although to date the number of confirmed cases is small, the signs are troubling. Formenty, a veteran of many Ebola outbreaks, noted that there have been suspected cases in at least two locations—Bikoro and a village called Ingende, which is nearly 40 miles away on roads that can only be traveled on motorbikes.

Among the suspected cases, there are individuals who cared for sick people, as well as people who attended funerals of suspected cases. Looking after someone sick with Ebola and taking part in traditional burial practices—which may involve washing and touching the deceased—are classic ways Ebola spreads through communities.

The regional hospital is in Bikoro. The WHO was informed Wednesday of four new suspected cases there, two of whom are health care workers. “Maybe these two health care workers are just severe malaria cases, but my gut feeling says probably not,” Formenty said.

Health care workers are at exceptionally high risk during an outbreak, especially during the early days before it’s clear that Ebola is present. The WHO’s expert advisers on vaccines have said in the past that they should be offered vaccination during an outbreak—and Formenty said he expects that to happen this time.

“So the heath care workers in the catchment area of this outbreak—which is quite large, by the way—are going also to be proposed to be vaccinated and to be part of the vaccine trial,” he said.

The final decision on whether to use an experimental vaccine being developed by Merck rests with the ministry of health. But Formenty noted that during an Ebola outbreak in the country last year, officials agreed to use the vaccine.

In that outbreak, transmission stopped after only eight cases and the vaccine was not deployed. But that earlier approval should speed the process of an emergency use authorization this time, he said.

Republished with permission from STAT. This article originally appeared on May 9, 2018

Helen Branswell is STAT's infectious diseases and public health reporter. She comes from the Canadian Press, where she was the medical reporter for the past 15 years. Helen cut her infectious diseases teeth during Toronto's SARS outbreak in 2003 and spent the summer of 2004 embedded at the US Centers for Disease Control and Prevention. In 2010-11 she was a Nieman Global Health Fellow at Harvard, where she focused on polio eradication. Warning: Helen asks lots of questions.

More by Helen Branswell

STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

More by STAT

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe